MyVisionTest News Archive

Displaying news items tagged with retinal vein occlusion (More tags »)
SELECT PAGE
First <<  1 2 3 4   >> Last

National Health Service
Feb 27, 2011
The North East Treatment Advisory Group (NETAG) has produced an appraisal of bevacizumab (Avastin) and ranibizumab (Lucentis), in the management of macular oedema secondary to retinal vein occlusion and recommended that bevacizumab 1.25 mg using a 'when required' (PRN) regimen is recommended for use within NHS North East as this regimen is...

Full Article


Central retinal vein occlusion
Oct 25, 2010
For the better part of the last 2 decades, there has been little debate as to the preferred treatment of retinal vein occlusion. Ever since the results of the Branch Vein Occlusion Study were published in 1984, gold standard therapy has called for grid laser photocoagulation to treat vision-reducing macular edema caused by branch retinal vein...

Full Article


Central retinal vein occlusion
Oct 16, 2010
Monthly Lucentis (ranibizumab) significantly increased best-corrected visual acuity (BCVA) and decreased macular edema, compared with sham, in patients with central retinal vein occlusion (CRVO), according to a new study. Until recently, there has been no effective therapy for macular edema secondary to central retinal vein occlusion (CRVO)....

Full Article


VEGF-Trap
Sep 20, 2010
The GALILEO study has recently started phase 3 to assess the efficacy and safety of VEGF Trap-Eye in the treatment of macular edema in central retinal vein occlusion, a speaker announced here. "Enrollment of 117 patients from 10 countries was completed in July," Frank Holz, MD, said at the Euretina meeting here preceding the European Society...

Full Article


Central retinal vein occlusion
Sep 20, 2010
Macular edema due to branch retinal vein occlusion or central retinal vein occlusion can be effectively reduced using the Ozurdex dexamethasone intravitreal implant, but early treatment is mandatory, according to data from the multicenter GENEVA study. "Patients who were treated early showed a visual acuity improvement of three or more lines,...

Full Article


Central retinal vein occlusion
Aug 26, 2010
The European Medicines Agency has granted Allergan marketing authorization for its dexamethasone intravitreal implant for treating macular edema secondary to retinal vein occlusion, the company announced in a press release. With the approval, Ozurdex (dexamethasone 0.7 mg intravitreal implant) becomes the first and only therapeutic agent...

Full Article


Branch retinal vein occlusion
Aug 19, 2010
Avastin (bevacizumab, IVB) accelerates recovery from macular edema following branch retinal vein occlusion (BRVO), but do not have any significant effects on visual acuity after 12 weeks. Retinal vein occlusion is a common cause of sudden vision loss in adults. Central retinal vein occlusion occurs when the main vein draining blood from the eye...

Full Article


Central retinal vein occlusion
Jul 21, 2010
Lucentis (ranibizumab) is safe and effective for treatment-naive retinal vein occlusion, according to a new study. Retinal vein occlusion is a common cause of sudden vision loss in adults. Central retinal vein occlusion occurs when the main vein draining blood from the eye become occluded, and branch retinal vein occlusion refers to occlusion...

Full Article


Lucentis
Jun 27, 2010
Following a 6-month priority review, the U.S. Food and Drug Administration has approved Lucentis (ranibizumab) for treatment of macular edema due to retinal vein occlusion, Genentech announced in a press release. "This approval provides an important new medicine for people experiencing the unexpected vision loss associated with macular edema...

Full Article


Branch retinal vein occlusion
May 8, 2010
Both Avastin (bevacizumab) and triamcinolone acetate (steroid) treatment of macular edema (ME) after branch retinal vein occlusion (BRVO) results in decreased macular thickness, but only Avastin improves visual acuity, according to a new study. Retinal vein occlusion is a common cause of sudden vision loss in adults. Central retinal vein...

Full Article


SELECT PAGE
First <<  1 2 3 4   >> Last
Most Popular
Less - past - More